Skip to main content

Peer Review reports

From: The impact of carboplatin on pathologic complete response and survival based on HER2 low and HER2 zero status in triple negative breast cancer patients receiving neoadjuvant chemotherapy: a multicenter real-world analysis

Original Submission
4 Dec 2024 Submitted Original manuscript
9 Feb 2025 Reviewed Reviewer Report
24 Feb 2025 Reviewed Reviewer Report
26 Feb 2025 Reviewed Reviewer Report
1 Mar 2025 Reviewed Reviewer Report
18 Mar 2025 Author responded Author comments - SEDAT YILDIRIM
20 Mar 2025 Author responded Author comments - SEDAT YILDIRIM
Resubmission - Version 2
18 Mar 2025 Submitted Manuscript version 2
6 Apr 2025 Reviewed Reviewer Report
15 Apr 2025 Reviewed Reviewer Report
22 Apr 2025 Author responded Author comments - SEDAT YILDIRIM
Resubmission - Version 3
22 Apr 2025 Submitted Manuscript version 3
23 Apr 2025 Author responded Author comments - SEDAT YILDIRIM
Resubmission - Version 4
23 Apr 2025 Submitted Manuscript version 4
24 Apr 2025 Reviewed Reviewer Report
27 Apr 2025 Reviewed Reviewer Report
29 Apr 2025 Author responded Author comments - SEDAT YILDIRIM
Resubmission - Version 5
29 Apr 2025 Submitted Manuscript version 5
Publishing
30 Apr 2025 Editorially accepted
6 May 2025 Article published 10.1186/s12885-025-14252-3

You can find further information about peer review here.

Back to article page